JAMP Digoxin 0.0625 mg and 0.125 mg tablets recalled due to possible incorrect dose, which may pose health risks
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety
What you should do
- If you are taking this medication, speak with your pharmacist as soon as possible. Your pharmacist will check if your product is affected and provide a replacement if needed. It may not be possible to know if you are getting the correct dose of digoxin by looking at the tablets. Overweight or underweight tablets may look like normal-sized tablets.
- Continue taking your JAMP Digoxin 0.0625 or 0.125 mg tablets until you speak with your pharmacist, as digoxin is an important drug when you have a heart condition.
- Contact a health care professional immediately if you or someone you are caring for experience serious side effects related to an overdose of digoxin or reduced efficacy of therapy.
- Contact JAMP Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at custjamp@jamppharma.com, if you have questions about this recall.
- Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.